Completion of EU GMP inspection by Belgium''s FAMPH at Innoxel Lifesciences Private Limited subsidiary Company of Bharat Parenterals Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Limited's subsidiary, Innoxel Lifesciences, has successfully completed an EU GMP inspection conducted by Belgium's Federal Agency for Medicines and Health Products (FAMHP) at its manufacturing facility in Vadodara, Gujarat. The inspection ran from November 24 to November 28, 2025, and was cleared with zero critical and zero major observations. This follows Innoxel's earlier successful USFDA inspection outcomes, further strengthening its regulatory credentials. EU GMP certification enables the company to manufacture and supply pharmaceutical products for the European Union market.
Positive for shareholders — zero-observation EU GMP clearance opens the door to EU-regulated markets, enhances export potential, and strengthens the company's positioning as a globally compliant pharma manufacturer, which could support future revenue growth from European clients.